As proof of the c-Myc up-regulation in the acquisition of cancer cells resistance to Palbociclib, it is reported that the simultaneous treatment with the c-Myc inhibitor JQ1 and Palbociclib resulted in a synergistic anti-tumor growth effect [63]. Here, MYC is linked to cancer.